These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29581811)

  • 1. Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.
    Minami S; Ihara S; Kim SH; Yamamoto S; Komuta K
    World J Oncol; 2018 Feb; 9(1):13-20. PubMed ID: 29581811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment Lymphocyte to Monocyte Ratio as a Prognostic Marker for Advanced Pulmonary Squamous Cell Carcinoma Treated With Chemotherapy.
    Minami S; Ihara S; Komuta K
    J Clin Med Res; 2018 Aug; 10(8):657-664. PubMed ID: 29977424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival of Advanced Non-Small Cell Lung Cancer Harboring Mutant Epidermal Growth Factor Receptor.
    Minami S; Ogata Y; Ihara S; Yamamoto S; Komuta K
    World J Oncol; 2017 Dec; 8(6):180-187. PubMed ID: 29317963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients.
    Cho A; Untersteiner H; Hirschmann D; Fitschek F; Dorfer C; Rössler K; Zöchbauer-Müller S; Gatterbauer B; Hochmair MJ; Frischer JM
    J Neurooncol; 2021 Jan; 151(2):257-265. PubMed ID: 33179214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy.
    Zhao K; Wang C; Shi F; Huang Y; Ma L; Li M; Song Y
    BMC Cancer; 2021 Jan; 21(1):66. PubMed ID: 33446134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
    Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
    Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients.
    Shang QX; Yang YS; Hu WP; Yuan Y; He Y; Zhao JY; Ji AF; Chen LQ
    Transl Cancer Res; 2020 Jun; 9(6):3903-3914. PubMed ID: 35117757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer.
    Minami S; Ogata Y; Ihara S; Yamamoto S; Komuta K
    Lung Cancer (Auckl); 2017; 8():249-257. PubMed ID: 29263709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs.
    Zhang Y; Feng YC; Zhu HG; Xiong TC; Hou YS; Song J; Jiang W; Zhu CJ
    Medicine (Baltimore); 2018 Jul; 97(30):e11648. PubMed ID: 30045314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of inflammation-based markers for predicting the prognosis of unresectable pancreatic ductal adenocarcinoma treated with chemotherapy.
    Asama H; Suzuki R; Takagi T; Sugimoto M; Konno N; Watanabe K; Nakamura J; Kikuchi H; Takasumi M; Sato Y; Irie H; Hikichi T; Ohira H
    Mol Clin Oncol; 2018 Oct; 9(4):408-414. PubMed ID: 30233794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of the Modified Systemic Inflammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma.
    Huang H; Chen LM; Fang XJ; Guo CC; Lin XP; Hong HM; Li X; Wang Z; Tian Y; Chen MT; Yao YY; Chen Z; Li XQ; Pan F
    Front Pharmacol; 2020; 11():593392. PubMed ID: 33101044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic values of systemic inflammation and nutrition-based prognostic indices in oropharyngeal carcinoma.
    Oka T; Sato F; Ono T; Kawaguchi T; Murotani K; Sueyoshi S; Kuroiwa T; Kurita T; Fukahori M; Mitsuhashi T; Sato K; Chitose SI; Umeno H
    Laryngoscope Investig Otolaryngol; 2023 Jun; 8(3):675-685. PubMed ID: 37342125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.
    Urabe M; Yamashita H; Watanabe T; Seto Y
    World J Surg; 2018 Jan; 42(1):185-194. PubMed ID: 28741195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non-small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores.
    McGovern J; O'Rourke F; Will S; Nguyen HTN; Cranfield E; Maseland C; MacLeod N; Maclay JD; Laird BJ; Dolan RD; McMillan DC
    Cancer Med; 2024 Aug; 13(16):e70139. PubMed ID: 39164973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
    Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
    Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis.
    Chan SWS; Smith E; Aggarwal R; Balaratnam K; Chen R; Hueniken K; Fazelzad R; Weiss J; Jiang S; Shepherd FA; Bradbury PA; Sacher AG; Leighl NB; Xu W; Brown MC; Eng L; Liu G
    Clin Lung Cancer; 2021 Sep; 22(5):390-407. PubMed ID: 33582072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer.
    Takamizawa Y; Shida D; Boku N; Nakamura Y; Ahiko Y; Yoshida T; Tanabe T; Takashima A; Kanemitsu Y
    BMC Cancer; 2020 Nov; 20(1):1092. PubMed ID: 33176752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.
    Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G
    Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
    Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
    Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.